In 2012, there were 1,493,147 reported neuromodulator procedures. In 2017, that number grew significantly to 2,106,415 procedures showing the world that the interest in Neurotoxin procedures is definitely growing. There is refinement in products and delivery systems and our esteemed SBS Faculty Member, Dr. Susan Weinkle has had the opportunity to experience all the products throughout her years in practice. In this video, Dr. Weinkle shares clinical data in what is coming to market, what products to use and where to use them, as well as how to optimize outcomes with your patients.
- What is hot off the press and what is coming
- Botulinum Toxin Type A: Are they all the same??
- Novel Stabilizing Peptide Excipient
- The latest studies
- Injection and new delivery techniques